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Table 1. Baseline characteristics of the groups.
Group A (n¼ 52) Group B (n ¼ 39)
Age 60  8 57  12
Men (%) 35 (67.7) 27 (69.2)
Hypertension (%) 29 (54.7) 24 (45.3)
Diabetes (%) 16 (30.8) 12 (30.8)
LDL-cholesterol (mg/dL) 130  42 128  37
Creatinine (mg/dL) 0.99  0.3 0.92  0.3
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Aım: Hyaluronic acid (HA), an important component of the extracellular matrix
which is mainly secreted from the vascular smooth muscle cells, has been demon-
strated to accelerate atherosclerosis through enhanced adhesion of leukocytes to
endothelial cells. The aim of this study is to investigate the relationship between serum
HA levels and the angiographic severity and extent of coronary artery disease.
Methods: One hundred and thirty-four individuals who underwent coronary angi-
ography due to a positive stress test were included in the study. Individuals who had at
least 50% percent stenosis in a major epicardial artery and a Gensini score 20
constituted the patient group (n¼68), and those who did not have any signiﬁcant
stenosis and with a Gensini score < 20 constituted the control group (n¼66). Serum
HA levels were determined using the ELISA method.
Results: Serum HA levels were signiﬁcantly higher in the patient group when
compared to the control group (1.92.2 ng/mL vs. 1.21.1 ng/mL, respectively;
p¼0.016). There was a positive and signiﬁcant correlation between serum HA levels
and the Gensini score (r¼0.346, p<0.001).
Conclusıon: Serum levels of HA are higher in individuals with signiﬁcant CAD when
compared to those without, and HA levels are positively correlated to the severity and
extent of CAD. The exact role of HA in CAD pathogenesis and its relationship with
cardiovascular disease should be elucidated with further studies.
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Purpose: In-stent restenosis (ISR) occurs in 16% to 44% of patients with coronary
artery disease treated with stenting. Clinical studies have suggested that the plasma
renin activity (PRA) may play a role in ISR. Angiotensin-convertig enzyme inhibitors
(ACE-I) have been reported to reduced the rate of ISR. This study aimed to clarify the
role of PRA in the development of ISR in patients treated with stenting and already
receiving ACE-I therapy.
Methods: The study popullation comprised 52 patients with ISR (group A) and 39
patients without ISR (group B). All patients were treated with ACE-I. In-stent
restenosis, was deﬁned as angiographic restenosis (> or ¼ 50% diameter stenosis over
one year after the intervention). Patients were excluded if they had heart failure of if
they were known to have a low ejection fraction (<40%), uncontrolled hypertension,
or overt nephropathy. PRA levels were measured at the time of coronary angiography.
Results: The mean patient age was 59 years. Most patients were men (68.1%).
Baseline characteristics including drug use were similar between groups (Table 1). NoC198 JACC Vosigniﬁcant differences was found among patients with and without in-stent restenosis
groups with respect to PRA (0.671.6 vs 0.570.9 ng/ml.h, P¼0.74).
Conclusıon: We did not ﬁnd any relationship between the PRA and angiographic
restenosis after coronary stenting.PP-293
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Aım: GRACE risk score (GS) is a scoring system with prognostic signiﬁcance in
acute coronary syndrome (ACS) patients. Increased epicardial adipose tissue thickness
is known to be associated with cardiovascular disorders. A study directly examining
the relationship between epicardial fat thickness (EFT) and GS were not found in the
literature. In this study, we aimed to assess the relationship between GS and EFT in
ACS patients.
Methods: We evaulated 162 patients, with non ST segment elevation myocardial
infarction (NonSTEMI) between October 2012-February 2013 (115 male, mean age;
66.612.8) in the study. EFT was measured at the end of the diastole and systole with
echocardiographic methods. The patients who have high in-hospital GS were included
in H-GS group (in-hospital GS>140) and who have high six- month GS were
included in H-GS6M group (six month GS>108). Other patients were included in
low-modarate GS groups. (LM-GS, LM-GS6M).
Fındıngs: The patients in H-GS and H-GS6M groups were older and they also had
lower blood pressures. According to the laboratory data, it was detected that c-reactive
protein and creatinine increased in H-GS and H-GS6M groups. LDL increased in H-
GS group, however there was no signiﬁcant difference between six- month GS groups.
End-systolic and end-diastolic EFT were signiﬁcantly higher in high-risk groups
compared to GS. Systolic functions of H-GS and H-GS6M groups were worse than
the low-modarate risk groups (Table 1 and 2). The best correlation was found to be
between GS and end-diastolic EFT (in hospital GS, r¼0.455; six month GS, r¼0.436)
(Table 3 and 4).
Results: EFT increased in H-GS and H-GS6M groups. EFT values measured at the
end of systole or diastole can be used for prognostic assessment of patients with ACS.
However, GRACE score and end-diastolic EFT had a better correlation level.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Table 1. Generel characteristics of the patients according to in hospital
GRACE score
GRACE score <
140 (n¼70)
GRACE score >
140 (n¼92) p value
Age (year) 57,2 (9,1) 73,7 (10,5) p<0,001
Gender (Male/Famale) 56/14 59/33 p¼0,020
Systolic Blood Pressure
(mmHg)
147,3 (27,7) 130,3 (31,1) p<0,001
Diastolic Blood Pressure
(mmHg)
85,5 (16,1 78,1 (19,5) p¼0,010
BMI (kg/m2) 28,5 (4,4) 26,7 (3,7) p¼0,060
Smoking 35 (%50) 50 (%54,1) p¼0,718
Hypertension 40 (%57,1) 44 (%47,8) p¼0,155
Diabetes 21 (%30,0) 33 (%35,9) p¼0,269
Glucose (mg/dl) 139,6 (60,3) 146,5 (70,3) p¼0,515
Total Cholesterol(mg/dl) 185,7 (44,9) 204,2 (55,9) p¼0,022
LDL-Cholesterol (mg/dl) 133,1 (37,9) 148,5 (43,9) p¼0,019
HDL-Cholesterol (mg/dl) 40,9 (15,9) 39,9 (9,8) p¼0,627
Triglyceride (mg/dl) 124,8 (71,4) 131,3 ( 96,8) p¼0,641
CRP (mg/dl) 1,63 (3,4) 2,68 (4,38) p¼0,013
Creatinine (mg/dl) 0,84 (0,2) 1,18( 0,57) p<0,001
Troponin-I (ng/dl) 31,6 (30,0) 31,1 (28,1) p¼0,951
Left Ventricle Ejection
Fraction (%)
47,8 (10,2) 43,3 (10,5) p¼0,008
Interventricular septum
(mm)
10,1(1,2) 10,1 (1,36) p¼0,726
Posterior Wall (mm) 9,8 ( 1,12) 9,9 (1,26) p¼0,761
Left Ventricle Mass Index
(g/m2)
94,3 (22,4) 109,4 (28,4) p¼0,002
Epikardiyal fat thickness
(end-systol, mm)
0,72 (0,17) 0,81 (0,12) p<0,001
Epikardiyal fat thickness
(end-diastol, mm)
0,46 (0,13) 0,54 (0,10) p<0,001
TAPSE (mm) 20,9 (4,1) 19,4 (3,6) p¼0,017
SYNTAX 20,6 (10,1) 21,2 ( 9,9) p¼0,625
LAD lesion 29 (%41,4) 35 (%38,0) p¼0,352
Cx lesion 17 (%24,3) 16 (%17,4) p¼0,156
RCA lesion 24 (%34,3) 41 (%44,6) p¼0,081
Intensive-care-unit stay
(day)
3,3 (1,2) 4,3 (2,9) p¼0,019
In-hospital stay (day) 5,6 (2,5) 6,9 (3,8) p¼0,020
BMI; Body mass index, LDL; Low density lipoprotein, HDL; High density lipoprotein, CRP;
C-reactive protein, LV; Left ventricle, TAPSE; Tricuspid annulus planimetric systolic excursion,
LAD; Left anterior descending artery, Cx; Circumﬂex artery, RCA; Right coronary artery
Table 2. General charasteristics of the patients according to the six month
GRACE score
GRACE score < 108
(Low-moderate risk
group) (n¼77)
GRACE score >
108
(High risk
group) (n¼85) p value
Age (year) 57,2 (9,2) 75,1 (9,3) p<0,001
Gender (male/female) 62/15 53/32 p¼0,011
Systolic BP (mmHg) 144,6 (28,5) 131,3 (31,5) p¼0,006
Diastolic BP (mmHg) 84,5 (16,6) 78,3 (19,5) p¼0,031
BMI (kg/m2) 27,2 (4,2) 26,8 (3,8) p¼0,330
Smoking 36 (%46,7) 45 (%52,9) p¼0,718
Hypertension 41 (%53,2) 43 (%50,6) p¼0,155
Diabetes 22 (%28,6) 32 (%37,6) p¼0,269
Blood glucose (mg/dl) 138,2 (59,8) 148,3 (71,2) p¼0,481
Total Kolesterol (mg/dl) 206,2 (55,0) 183,1 (44,1) p¼0,166
LDL Kolesterol (mg/dl) 147,7 (43,0) 131,6 (38,1) p¼0,226
HDL Cholesterol (mg/dl) 41,1 (14,4) 39,8 (9,4) p¼0,723
Triglyceride (mg/dl) 130,2 (82,3) 126,8 ( 90,6) p¼0,867
CRP (mg/l) 1,73 (3,71) 2,68 (4,25) p¼0,050
Creatinine (mg/dl) 0,84 (0,21) 1,21( 0,58) p<0,001
Troponin-I (ng/ml) 31,5 (31,0) 31,2 (29,5) p¼0,869
LV Ejection Fraction (%) 47,3 (10,1) 43,2 (10,6) p¼0,013
Interventriküler septum
(mm)
10,0(1,3) 10,1 (1,3) p¼0.869
Posterior Wall (mm) 9,9 ( 1,1) 9,7 (1,2) p¼0,875
LV mass index(g/m2) 94,7 (24,8) 109,8 (26,6) p¼0,004
Epicardial fat
thickness(diastol) (mm)
0,72 (0,18) 0,83 (0,13) p<0,001
Epicardial fat
thickness(diastol) (mm)
0,46 (0,12) 0,53 (0,14) p<0,001
TAPSE (mm) 20,7 (3,9) 19,3 (3,6) p¼0,010
SYNTAX score 20,6 (10,2) 21,3 ( 9,7) p¼0,685
LAD lesion 29 (%37,7) 35 (%41,2) p¼0,661
Cx lesion 18 (%23,4) 15 (%17,6) p¼0,452
RCA lesion 30 (%39,0) 35 (%41,2) p¼0,713
Intensive care unit stay
(days)
3,5 (1,4) 4,4 (2,9) p¼0,003
In hospital stay (days) 5,7 (2,5) 6,9 (3,8) p¼0.004
BP; Blood pressure, BM_I; Body mass index, LDL; Low density lipoprotein, HDL; High density
lipoprotein, CRP; C-reactive protein, LV; Left ventricle, TAPSE; Tricuspid annulus systolic
excursion, LAD; Left anterior descending artery, Cx; Circumﬂex artery, RCA; Right coronary
artery
Table 3. ROC analysis results
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EFT end sistol / GS 0.765 %67 %64 0.699 0.613-0.785
EFT end diastol / GS 0.465 %82 %60 0.702 0.613-0.785
EFT end sistol / GS-6M 0.725 %82 %62 0.720 0.629-0.811
EFT end diastol/ GS-6M 0.465 %80 %64 0.714 0.624-0.804
GS; GRACE score in hospital, GS-6M; GRACE score six months
JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS C199
P
O
S
T
E
R
S
Correlation table
Correlation factor (r)
End sistolic EFT - GS r¼0.387
End diastolic EFT - GS r¼0.438
End sistolic EFT - GS6M r¼0.406
End diastolic EFT - GS6M r¼0.455
End sistolic EFT - SYNTAX score r¼0.243
End diastolic EFT - SYNTAX score r¼0.202
GS; GRACE score in hospital, GS-6M; GRACE score for six months. EFT; Epicardial fat
thickness,
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Objectıve: It is unclear whether changes in plasma levels of inﬂammatory markers
could explain the link between ischemia and slow coronary ﬂow (SCF). We aimed to
evaluate the plasma levels of high-sensitivity C-reactive protein (hsCRP), interleukin
(IL)-6, and myeloperoxidase (MPO) during myocardial perfusion imaging (MPI) in
SCF patients.
Methods: Study population consisted of 53 SCF patients and 30 controls. Coronary
ﬂow rates were documented by TIMI frame count (TFC). Plasma levels of hsCRP, IL-
6, MPO, and MPI were obtained in all participants.
Results: The hsCRP, IL-6 and MPO levels of SCF patients were higher than controls
(hsCRP: 4.7  2.5 vs. 1.7  1.1 mg/L, p<0.001; IL-6: 8.2  4.3 vs. 5.2  2.1 pg/mL,
p<0.001; and MPO: 75.9  59.6 vs. 24.3  16.7 ng/mL, p<0.001). Twenty-one SCF
patients exhibited myocardial perfusion defect (MPD) on MPI. In SCF patients, the
highest hsCRP, IL-6 and MPO were observed in patients with both MPD and three-
vessel slow ﬂow. Mean TFCs were positively correlated with plasma levels of hsCRP
(r¼0.424, p¼0.002), IL-6 (r¼0.367, p¼0.007), MPO (r¼0.430, p¼0.001), and
reversibility score (r¼0.671, p<0.001) in SCF patients. HsCRP and MPO were the
independent variables, which predicted positive MPI-results (hsCRP: OR, 2.176; 95%
CI, 1.200 to 3.943; p¼0.010, MPO: OR, 1.026; 95% CI, 1.007 to 1.046; p¼0.008).
Conclusıon: Inﬂammation might play a crucial role in both the pathogenesis and
development of ischemia in SCF. Association of increased levels of inﬂammatory
markers and ischemia suggests that endothelial inﬂammation might be largely
responsible for clinical presentation. New combined treatment regimens should target
at endothelial activation and inﬂammation in SCF.
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Aım: QT dispersion (QTd) is a measure of inhomogeneity of myocardial repolari-
zation, increases following impaired myocardial perfusion and its prolongation may
provide a suitable substrate for life-threatening ventricular arrhythmias. We investi-
gated the changes in QTd and heart rate variability (HRV) parameters after successful
coronary artery revascularization in patient with chronic total occlusions (CTO).
Methods: One hundred and thirty nine successfully revascularized CTO patients were
included in this study (118 men, 21 women, mean age 58.39.6 years). QTd was
measured from a 12-lead electrocardiogram and QTd was deﬁned as the difference
between maximum and minimum QT interval. HRV analyses of all subjects were
obtained. Frequency domain (LF:HF) and time domain (SDNN, pNN50 and rMSSD)
parameters were analyzed. QT intervals were also corrected for heart rate using the
Bazett's formula, and the corrected QT interval dispersion (QTcd) was then calculated.
All measurements were made before and after percutaneous coronary intervention
(PCI).
Results: Both QTd and QTcd showed signiﬁcant improvement following successfully
revascularization of CTO (55.8314.79 to 38.8711.69; p<0.001 and 61.0216.28
to 42.9213.41; p<0.001). The revascularization of LAD (n¼38), Cx (n¼28) and
RCA (n¼73) resulted in decrease in HRV indices including SDDN, rMSSD and
pNN50, however none of the variables reached statistical signiﬁcance.
Conclusıon: Successful revascularization of CTO may result in improvement in
regional heterogeneity of myocardial repolarization, evidenced as decreased QTcd
after the PCI. The revascularization in CTO lesions does not seem to have a signiﬁcant
impact on HRV.C200 JACC VoPP-296
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Introductıon: Vitronectin (VN), a 459 aminoacid long glycoprotein with a mass of 75
kDa, is found in plasma, extracellular matrix (ECM) and a granules of platelets. VN
functions as a regulator of platelet adhesion and aggregation, coagulation and ﬁbri-
nolysis. Plasma VN levels were found to be elevated in patients with coronary artery
disease (CAD), and a positive correlation between VN levels and CAD severity has
been demonstrated. VN was also shown to be an independent predictor of adverse
cardiovascular outcomes following acute stenting in patients with acute coronary
syndromes (ACS) or stable angina.
The aim of this study was to investigate the diagnostic role of serum VN level at
admission in patients with ACS. The relation between extent of CAD and VN levels
was also investigated.
Methods: Sixty-two patients (40 men, mean age 59.910.3 years and 22 women,
mean age 68.911.2 years), who had been admitted to coronary care unit with ﬁrst
time diagnosis of ACS (ST elevation myocardial infarction [STEMI], non-ST eleva-
tion myocardial infarction [NSTEMI]) were consecutively included in the study.The
control group consisted of 18 stable patients in whom normal coronary arteries were
documented in coronary angiography. Patients were divided into two sub-groups as
STEMI and NSTEMI. Blood samples were drawn within 6 hours after onset of chest
pain and serum VN, high sensitive C-reactive protein (hs-CRP) and N-terminal pro-
brain natriuretic peptide (NT-proBNP) levels were measured using an enzyme
immunoassay method. Also, TIMI and GRACE clinical risk scores were calculated on
admission for all ACS patients. Appropriate statistical methods were utilized to
evaluate the diagnostic value of VN in ACS.
Results: The VN serum levels were demonstrated to be higher in MI patients
(7.0011.94 mg/ml in STEMI group, 7.7218.02 mg/ml in NSTEMI group vs.
1.812.22 mg/ml in controls, p¼0.012). When VN levels were compared between
STEMI and NSTEMI groups, no signiﬁcant differences were observed (p¼0.41).
Also, there was a signiﬁcant positive correlation between VN levels and Gensini score
only in NSTEMI patients (r¼0.436, p¼0.013). When the diagnostic value of VN
levels for MI was investigated, a cut-off value of 1.59 mg/ml yielded a sensitivity of
64%, a speciﬁcity of 84%, a positive predictive value of 93%, and a negative
predictive value of 41%. Also, when the diagnostic utility of VN was assessed using
ROC analysis, an area under the curve (AUC) of 0.72 was found (95% CI: 0.60-0.84;
p¼0.004; Figure).
Conclusıon: The present study demonstrate that, VN may have a utility as a diag-
nostic marker in patients with ACS. Also, VN may have a role to predict extension
and severity of CAD in patients with NSTEMI.PP-297
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Aım: Angiopoietin-like protein-6 (Angptl6) is a growth factor which enhances the
survival of hematopoietic stem cells. It is hypothesized that it may exert an anti-
atherosclerotic effect through enhanced survival of endothelial progenitor cells. Thel 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
